No retraction, correction or concern found when last checked on Oct 19, 2026.
The Intestinal Microbiota in Metabolic Disease
Anni Woting, Michael Blaut
Nutrients · 2016 · Review · CC BY
Abstract
Gut bacteria exert beneficial and harmful effects in metabolic diseases as deduced from the comparison of germfree and conventional mice and from fecal transplantation studies. Compositional microbial changes in diseased subjects have been linked to adiposity, type 2 diabetes and dyslipidemia. Promotion of an increased expression of intestinal nutrient transporters or a modified lipid and bile acid metabolism by the intestinal microbiota could result in an increased nutrient absorption by the host. The degradation of dietary fiber and the subsequent fermentation of monosaccharides to short-chain fatty acids (SCFA) is one of the most controversially discussed mechanisms of how gut bacteria impact host physiology. Fibers reduce the energy density of the diet, and the resulting SCFA promote intestinal gluconeogenesis, incretin formation and subsequently satiety. However, SCFA also deliver energy to the host and support liponeogenesis. Thus far, there is little knowledge on bacterial species that promote or prevent metabolic disease. Clostridium ramosum and Enterococcus cloacae were demonstrated to promote obesity in gnotobiotic mouse models, whereas bifidobacteria and Akkermansia muciniphila were associated with favorable phenotypes in conventional mice, especially when oligofructose was fed. How diet modulates the gut microbiota towards a beneficial or harmful composition needs further research. Gnotobiotic animals are a valuable tool to elucidate mechanisms underlying diet–host–microbe interactions.
References 117
- 1.
Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., Duncan A., Ley R.E., Sogin M.L., Jones W.J., Roe B.A., Affourtit J.P., et al. A core gut microbiome in obese and lean twins. Nature. 2009;457:480-484.
Not in our library10.1038/nature07540
- 2.
Hildebrandt M.A., Hoffmann C., Sherrill-Mix S.A., Keilbaugh S.A., Hamady M., Chen Y.Y., Knight R., Ahima R.S., Bushman F., Wu G.D. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology. 2009;137.
Not in our library10.1053/j.gastro.2009.08.042
- 3.
Murphy E.F., Cotter P.D., Healy S., Marques T.M., O’Sullivan O., Fouhy F., Clarke S.F., O’Toole P.W., Quigley E.M., Stanton C., et al. Composition and energy harvesting capacity of the gut microbiota: Relationship to diet, obesity and time in mouse models. Gut. 2010;59:1635-1642.
Not in our library10.1136/gut.2010.215665
- 4.
Maukonen J., Simoes C., Saarela M. The currently used commercial DNA-extraction methods give different results of clostridial and actinobacterial populations derived from human fecal samples. FEMS Microbiol. Ecol. 2012;79:697-708.
Not in our library10.1111/j.1574-6941.2011.01257.x
- 5.
Eckburg P.B., Bik E.M., Bernstein C.N., Purdom E., Dethlefsen L., Sargent M., Gill S.R., Nelson K.E., Relman D.A. Diversity of the human intestinal microbial flora. Science. 2005;308:1635-1638.
Not in our library10.1126/science.1110591
- 6.
Gill S.R., Pop M., Deboy R.T., Eckburg P.B., Turnbaugh P.J., Samuel B.S., Gordon J.I., Relman D.A., Fraser-Liggett C.M., Nelson K.E. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312:1355-1359.
Not in our library10.1126/science.1124234
- 7.
Flint H.J., Scott K.P., Duncan S.H., Louis P., Forano E. Microbial degradation of complex carbohydrates in the gut. Gut Microbes. 2012;3:289-306.
Not in our library10.4161/gmic.19897
- 8.
D’Elia J.N., Salyers A.A. Effect of regulatory protein levels on utilization of starch by Bacteroides thetaiotaomicron. J. Bacteriol. 1996;178:7180-7186.
Not in our library10.1128/jb.178.24.7180-7186.1996
- 9.
Shipman J.A., Berleman J.E., Salyers A.A. Characterization of four outer membrane proteins involved in binding starch to the cell surface of Bacteroides thetaiotaomicron. J. Bacteriol. 2000;182:5365-5372.
Not in our library10.1128/jb.182.19.5365-5372.2000
- 10.
Ze X., Ben David Y., Laverde-Gomez J.A., Dassa B., Sheridan P.O., Duncan S.H., Louis P., Henrissat B., Juge N., Koropatkin N.M., et al. Unique Organization of Extracellular Amylases into Amylosomes in the Resistant Starch-Utilizing Human Colonic Firmicutes Bacterium Ruminococcus bromii. mBio. 2015;6.
Not in our library10.1128/mbio.01058-15
- 11.
Sonnenburg J.L., Xu J., Leip D.D., Chen C.H., Westover B.P., Weatherford J., Buhler J.D., Gordon J.I. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science. 2005;307:1955-1959.
Not in our library10.1126/science.1109051
- 12.
Turroni F., Bottacini F., Foroni E., Mulder I., Kim J.H., Zomer A., Sanchez B., Bidossi A., Ferrarini A., Giubellini V., et al. Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging. Proc. Natl. Acad. Sci. USA. 2010;107:19514-19519.
Not in our library10.1073/pnas.1011100107
- 13.
Derrien M., Collado M.C., Ben-Amor K., Salminen S., de Vos W.M. The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl. Environ. Microbiol. 2008;74:1646-1648.
Not in our library10.1128/aem.01226-07
- 14.
Sonnenburg E.D., Sonnenburg J.L., Manchester J.K., Hansen E.E., Chiang H.C., Gordon J.I. A hybrid two-component system protein of a prominent human gut symbiont couples glycan sensing in vivo to carbohydrate metabolism. Proc. Natl. Acad. Sci. USA. 2006;103:8834-8839.
Not in our library10.1073/pnas.0603249103
- 15.
Sonnenburg E.D., Zheng H., Joglekar P., Higginbottom S.K., Firbank S.J., Bolam D.N., Sonnenburg J.L. Specificity of polysaccharide use in intestinal bacteroides species determines diet-induced microbiota alterations. Cell. 2010;141:1241-1252.
Not in our library10.1016/j.cell.2010.05.005
- 16.
Lynch J.B., Sonnenburg J.L. Prioritization of a plant polysaccharide over a mucus carbohydrate is enforced by a bacteroides hybrid two-component system. Mol. Microbiol. 2012;85:478-491.
Not in our library10.1111/j.1365-2958.2012.08123.x
- 17.
Macfarlane G.T., Macfarlane S. Factors affecting fermentation reactions in the large bowel. Proc. Nutr. Soc. 1993;52:367-373.
Not in our library10.1079/pns19930072
- 18.
Smith E.A., Macfarlane G.T. Studies on amine production in the human colon: Enumeration of amine forming bacteria and physiological effects of carbohydrate and pH. Anaerobe. 1996;2:285-297.
Not in our library10.1006/anae.1996.0037
- 19.
Smith E.A., Macfarlane G.T. Formation of phenolic and indolic compounds by anaerobic bacteria in the human large intestine. Microb. Ecol. 1997;33:180-188.
Not in our library10.1007/s002489900020
- 20.
Smith E.A., Macfarlane G.T. Dissimilatory amino acid metabolism in human colonic bacteria. Anaerobe. 1997;3:327-337.
Not in our library10.1006/anae.1997.0121
- 21.
Budnowski J., Hanske L., Schumacher F., Glatt H., Platz S., Rohn S., Blaut M. Glucosinolates are mainly absorbed intact in germfree and human microbiota-associated mice. J. Agric. Food. Chem. 2015;63:8418-8428.
Not in our library10.1021/acs.jafc.5b02948
- 22.
Luang-In V., Narbad A., Nueno-Palop C., Mithen R., Bennett M., Rossiter J.T. The metabolism of methylsulfinylalkyl- and methylthioalkyl-glucosinolates by a selection of human gut bacteria. Mol. Nutr. Food Res. 2014;58:875-883.
Not in our library10.1002/mnfr.201300377
- 23.
Braune A., Blaut M. Bacterial species involved in the conversion of dietary flavonoids in the human gut. Gut Microbes. 2016.
Not in our library10.1080/19490976.2016.1158395
- 24.
Ridlon J.M., Kang D.J., Hylemon P.B., Bajaj J.S. Bile acids and the gut microbiome. Curr. Opin. Gastroenterol. 2014;30:332-338.
Not in our library10.1097/mog.0000000000000057
- 25.
Islam K.B.M.S., Fukiya S., Hagio M., Fujii N., Ishizuka S., Ooka T., Ogura Y., Hayashi T., Yokota A. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology. 2011;141:1773-1781.
Not in our library10.1053/j.gastro.2011.07.046
- 26.
Backhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., Semenkovich C.F., Gordon J.I. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA. 2004;101:15718-15723.
Not in our library10.1073/pnas.0407076101
- 27.
Backhed F., Manchester J.K., Semenkovich C.F., Gordon J.I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl. Acad. Sci. USA. 2007;104:979-984.
Not in our library10.1073/pnas.0605374104
- 28.
Samuel B.S., Shaito A., Motoike T., Rey F.E., Backhed F., Manchester J.K., Hammer R.E., Williams S.C., Crowley J., Yanagisawa M., et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, GPR41. Proc. Natl. Acad. Sci. USA. 2008;105:16767-16772.
Not in our library10.1073/pnas.0808567105
- 29.
Rabot S., Membrez M., Bruneau A., Gerard P., Harach T., Moser M., Raymond F., Mansourian R., Chou C.J. Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. FASEB J. 2010;24:4948-4959.
Not in our library10.1096/fj.10-164921
- 30.
Fleissner C.K., Huebel N., Abd El-Bary M.M., Loh G., Klaus S., Blaut M. Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br. J. Nutr. 2010;104:919-929.
Not in our library10.1017/s0007114510001303
- 31.
Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027-1031.
Not in our library10.1038/nature05414
- 32.
Turnbaugh P.J., Ridaura V.K., Faith J.J., Rey F.E., Knight R., Gordon J.I. The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med. 2009;1:6ra14.
Not in our library10.1126/scitranslmed.3000322
- 33.
Ridaura V.K., Faith J.J., Rey F.E., Cheng J., Duncan A.E., Kau A.L., Griffin N.W., Lombard V., Henrissat B., Bain J.R., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013;341:1241214.
Not in our library10.1126/science.1241214
- 34.
Faith J.J., McNulty N.P., Rey F.E., Gordon J.I. Predicting a human gut microbiota’s response to diet in gnotobiotic mice. Science. 2011;333:101-104.
Not in our library10.1126/science.1206025
- 35.
David L.A., Maurice C.F., Carmody R.N., Gootenberg D.B., Button J.E., Wolfe B.E., Ling A.V., Devlin A.S., Varma Y., Fischbach M.A., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505:559-563.
Not in our library10.1038/nature12820
- 36.
Carmody R.N., Gerber G.K., Luevano J.M., Gatti D.M., Somes L., Svenson K.L., Turnbaugh P.J. Diet dominates host genotype in shaping the murine gut microbiota. Cell Host Microbe. 2015;17:72-84.
Not in our library10.1016/j.chom.2014.11.010
- 37.
Turnbaugh P.J., Backhed F., Fulton L., Gordon J.I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008;3:213-223.
Not in our library10.1016/j.chom.2008.02.015
- 38.
Ley R.E., Backhed F., Turnbaugh P., Lozupone C.A., Knight R.D., Gordon J.I. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA. 2005;102:11070-11075.
Not in our library10.1073/pnas.0504978102
- 39.
Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: Human gut microbes associated with obesity. Nature. 2006;444:1022-1023.
Not in our library10.1038/4441022a
- 40.
Furet J.P., Kong L.C., Tap J., Poitou C., Basdevant A., Bouillot J.L., Mariat D., Corthier G., Dore J., Henegar C., et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: Links with metabolic and low-grade inflammation markers. Diabetes. 2010;59:3049-3057.
Not in our library10.2337/db10-0253
- 41.
- 42.
Duncan S.H., Lobley G.E., Holtrop G., Ince J., Johnstone A.M., Louis P., Flint H.J. Human colonic microbiota associated with diet, obesity and weight loss. Int. J. Obes. 2008;32:1720-1724.
Not in our library10.1038/ijo.2008.155
- 43.
Schwiertz A., Taras D., Schafer K., Beijer S., Bos N.A., Donus C., Hardt P.D. Microbiota and scfa in lean and overweight healthy subjects. Obesity. 2010;18:190-195.
Not in our library10.1038/oby.2009.167
- 44.
Devkota S., Wang Y., Musch M.W., Leone V., Fehlner-Peach H., Nadimpalli A., Antonopoulos D.A., Jabri B., Chang E.B. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in il10-/- mice. Nature. 2012;487:104-108.
Not in our library10.1038/nature11225
- 45.
Samuel B.S., Gordon J.I. A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. Proc. Natl. Acad. Sci. USA. 2006;103:10011-10016.
Not in our library10.1073/pnas.0602187103
- 46.
Isken F., Klaus S., Osterhoff M., Pfeiffer A.F., Weickert M.O. Effects of long-term soluble vs. Insoluble dietary fiber intake on high-fat diet-induced obesity in C57BL/6J mice. J. Nutr. Biochem. 2010;21:278-284.
Not in our library10.1016/j.jnutbio.2008.12.012
- 47.
- 48.
Slavin J.L. Dietary fiber and body weight. Nutrition. 2005;21:411-418.
Not in our library10.1016/j.nut.2004.08.018
- 49.
- 50.
Rahat-Rozenbloom S., Fernandes J., Gloor G.B., Wolever T.M.S. Evidence for greater production of colonic short-chain fatty acids in overweight than lean humans. Int. J. Obes. 2014;38:1525-1531.
Not in our library10.1038/ijo.2014.46
- 51.
Teixeira T.F., Grzeskowiak L., Franceschini S.C., Bressan J., Ferreira C.L., Peluzio M.C. Higher level of faecal scfa in women correlates with metabolic syndrome risk factors. Br. J. Nutr. 2013;109:914-919.
Not in our library10.1017/s0007114512002723
- 52.
Weickert M.O., Arafat A.M., Blaut M., Alpert C., Becker N., Leupelt V., Rudovich N., Mohlig M., Pfeiffer A.F. Changes in dominant groups of the gut microbiota do not explain cereal-fiber induced improvement of whole-body insulin sensitivity. Nutr. Metab. 2011;8:90.
Not in our library10.1186/1743-7075-8-90
- 53.
Weickert M.O., Roden M., Isken F., Hoffmann D., Nowotny P., Osterhoff M., Blaut M., Alpert C., Gogebakan O., Bumke-Vogt C., et al. Effects of supplemented isoenergetic diets differing in cereal fiber and protein content on insulin sensitivity in overweight humans. Am. J. Clin. Nutr. 2011;94:459-471.
Not in our library10.3945/ajcn.110.004374
- 54.
Hooper L.V., Wong M.H., Thelin A., Hansson L., Falk P.G., Gordon J.I. Molecular analysis of commensal host-microbial relationships in the intestine. Science. 2001;291:881-884.
Not in our library10.1126/science.291.5505.881
- 55.
- 56.
Wostmann B.S. The germfree animal in nutritional studies. Annu. Rev. Nutr. 1981;1:257-279.
Not in our library10.1146/annurev.nu.01.070181.001353
- 57.
Sayin S.I., Wahlstrom A., Felin J., Jantti S., Marschall H.U., Bamberg K., Angelin B., Hyotylainen T., Oresic M., Backhed F. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring fxr antagonist. Cell Metab. 2013;17:225-235.
Not in our library10.1016/j.cmet.2013.01.003
- 58.
Begley M., Hill C., Gahan C.G. Bile salt hydrolase activity in probiotics. Appl. Environ. Microbiol. 2006;72:1729-1738.
Not in our library10.1128/aem.72.3.1729-1738.2006
- 59.
Semova I., Carten J.D., Stombaugh J., Mackey L.C., Knight R., Farber S.A., Rawls J.F. Microbiota regulate intestinal absorption and metabolism of fatty acids in the zebrafish. Cell Host Microbe. 2012;12:277-288.
Not in our library10.1016/j.chom.2012.08.003
- 60.
- 61.
Wang T.Y., Liu M., Portincasa P., Wang D.Q.H. New insights into the molecular mechanism of intestinal fatty acid absorption. Eur. J. Clin. Investig. 2013;43:1203-1223.
Not in our library10.1111/eci.12161
- 62.
Voshol P.J., Rensen P.C., van Dijk K.W., Romijn J.A., Havekes L.M. Effect of plasma triglyceride metabolism on lipid storage in adipose tissue: Studies using genetically engineered mouse models. Biochim. Biophys. Acta. 2009;1791:479-485.
Not in our library10.1016/j.bbalip.2008.12.015
- 63.
Kim I., Kim H.G., Kim H., Kim H.H., Park S.K., Uhm C.S., Lee Z.H., Koh G.Y. Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis. Biochem. J. 2000;346 Pt 3:603-610.
Not in our library10.1042/bj3460603
- 64.
Kersten S., Mandard S., Tan N.S., Escher P., Metzger D., Chambon P., Gonzalez F.J., Desvergne B., Wahli W. Characterization of the fasting-induced adipose factor fiaf, a novel peroxisome proliferator-activated receptor target gene. J. Biol. Chem. 2000;275:28488-28493.
Not in our library10.1074/jbc.m004029200
- 65.
Yoon J.C., Chickering T.W., Rosen E.D., Dussault B., Qin Y., Soukas A., Friedman J.M., Holmes W.E., Spiegelman B.M. Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation. Mol. Cell Biol. 2000;20:5343-5349.
Not in our library10.1128/mcb.20.14.5343-5349.2000
- 66.
Sukonina V., Lookene A., Olivecrona T., Olivecrona G. Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc. Natl. Acad. Sci. USA. 2006;103:17450-17455.
Not in our library10.1073/pnas.0604026103
- 67.
Lichtenstein L., Kersten S. Modulation of plasma TG lipolysis by angiopoietin-like proteins and GPIHBP1. Biochim. Biophys. Acta. 2010;1801:415-420.
Not in our library10.1016/j.bbalip.2009.12.015
- 68.
Mandard S., Zandbergen F., van Straten E., Wahli W., Kuipers F., Muller M., Kersten S. The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J. Biol. Chem. 2006;281:934-944.
Not in our library10.1074/jbc.m506519200
- 69.
- 70.
Blaut M., Klaus S. Intestinal microbiota and obesity. Handb. Exp. Pharmacol. 2012;251-273.
Not in our library10.1007/978-3-642-24716-3_11
- 71.
Brown A.J., Goldsworthy S.M., Barnes A.A., Eilert M.M., Tcheang L., Daniels D., Muir A.I., Wigglesworth M.J., Kinghorn I., Fraser N.J., et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 2003;278:11312-11319.
Not in our library10.1074/jbc.m211609200
- 72.
Xiong Y., Miyamoto N., Shibata K., Valasek M.A., Motoike T., Kedzierski R.M., Yanagisawa M. Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc. Natl. Acad. Sci. USA. 2004;101:1045-1050.
Not in our library10.1073/pnas.2637002100
- 73.
Tazoe H., Otomo Y., Kaji I., Tanaka R., Karaki S.I., Kuwahara A. Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. J. Physiol. Pharmacol. 2008;59(Suppl. 2):251-262.
Not in our library
- 74.
- 75.
Tolhurst G., Heffron H., Lam Y.S., Parker H.E., Habib A.M., Diakogiannaki E., Cameron J., Grosse J., Reimann F., Gribble F.M. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2012;61:364-371.
Not in our library10.2337/db11-1019
- 76.
- 77.
Blaut M. Gut microbiota and energy balance: Role in obesity. Proc. Nutr. Soc. 2015;74:227-234.
Not in our library10.1017/s0029665114001700
- 78.
De Vadder F., Kovatcheva-Datchary P., Goncalves D., Vinera J., Zitoun C., Duchampt A., Backhed F., Mithieux G. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell. 2014;156:84-96.
Not in our library10.1016/j.cell.2013.12.016
- 79.
Delaere F., Duchampt A., Mounien L., Seyer P., Duraffourd C., Zitoun C., Thorens B., Mithieux G. The role of sodium-coupled glucose co-transporter 3 in the satiety effect of portal glucose sensing. Mol. Metab. 2012;2:47-53.
Not in our library10.1016/j.molmet.2012.11.003
- 80.
Mithieux G. Nutrient control of energy homeostasis via gut-brain neural circuits. Neuroendocrinology. 2014;100:89-94.
Not in our library10.1159/000369070
- 81.
Wang A., Si H., Liu D., Jiang H. Butyrate activates the cAMP-protein kinase A-cAMP response element-binding protein signaling pathway in Caco-2 cells. J. Nutr. 2012;142:1-6.
Not in our library10.3945/jn.111.148155
- 82.
Hotamisligil G.S. Inflammation and metabolic disorders. Nature. 2006;444:860-867.
Not in our library10.1038/nature05485
- 83.
Cani P.D., Osto M., Geurts L., Everard A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes. 2012;3:279-288.
Not in our library10.4161/gmic.19625
- 84.
Creely S.J., McTernan P.G., Kusminski C.M., Fisher F.M., Da Silva N.F., Khanolkar M., Evans M., Harte A.L., Kumar S. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 2007;292:E740-E747.
Not in our library10.1152/ajpendo.00302.2006
- 85.
Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., Neyrinck A.M., Fava F., Tuohy K.M., Chabo C., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56:1761-1772.
Not in our library10.2337/db06-1491
- 86.
Erridge C., Attina T., Spickett C.M., Webb D.J. A high-fat meal induces low-grade endotoxemia: Evidence of a novel mechanism of postprandial inflammation. Am. J. Clin. Nutr. 2007;86:1286-1292.
Not in our library10.1093/ajcn/86.5.1286
- 87.
Amar J., Burcelin R., Ruidavets J.B., Cani P.D., Fauvel J., Alessi M.C., Chamontin B., Ferrieres J. Energy intake is associated with endotoxemia in apparently healthy men. Am. J. Clin. Nutr. 2008;87:1219-1223.
Not in our library10.1093/ajcn/87.5.1219
- 88.
Kitchens R.L., Thompson P.A. Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J. Endotoxin Res. 2005;11:225-229.
Not in our library10.1177/09680519050110040701
- 89.
Hersoug L.G., Moller P., Loft S. Gut microbiota-derived lipopolysaccharide uptake and trafficking to adipose tissue: Implications for inflammation and obesity. Obes. Rev. 2016;17:297-312.
Not in our library10.1111/obr.12370
- 90.
- 91.
Liu J., Batkai S., Pacher P., Harvey-White J., Wagner J.A., Cravatt B.F., Gao B., Kunos G. Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor. J. Biol. Chem. 2003;278:45034-45039.
Not in our library10.1074/jbc.m306062200
- 92.
Muccioli G.G., Naslain D., Backhed F., Reigstad C.S., Lambert D.M., Delzenne N.M., Cani P.D. The endocannabinoid system links gut microbiota to adipogenesis. Mol. Syst. Biol. 2010;6:392.
Not in our library10.1038/msb.2010.46
- 93.
Kless C., Muller V.M., Schuppel V.L., Lichtenegger M., Rychlik M., Daniel H., Klingenspor M., Haller D. Diet-induced obesity causes metabolic impairment independent of alterations in gut barrier integrity. Mol. Nutr. Food Res. 2015;59:968-978.
Not in our library10.1002/mnfr.201400840
- 94.
Johnson R.J., Rivard C., Lanaspa M.A., Otabachian-Smith S., Ishimoto T., Cicerchi C., Cheeke P.R., Macintosh B., Hess T. Fructokinase, fructans, intestinal permeability, and metabolic syndrome: An equine connection? J. Equine Vet. Sci. 2013;33:120-126.
Not in our library10.1016/j.jevs.2012.05.004
- 95.
Ferrer M., Ruiz A., Lanza F., Haange S.B., Oberbach A., Till H., Bargiela R., Campoy C., Segura M.T., Richter M., et al. Microbiota from the distal guts of lean and obese adolescents exhibit partial functional redundancy besides clear differences in community structure. Environ. Microbiol. 2013;15:211-226.
Not in our library10.1111/j.1462-2920.2012.02845.x
- 96.
Karlsson F.H., Tremaroli V., Nookaew I., Bergstrom G., Behre C.J., Fagerberg B., Nielsen J., Backhed F. Gut metagenome in european women with normal, impaired and diabetic glucose control. Nature. 2013;498:99-103.
Not in our library10.1038/nature12198
- 97.
Le Chatelier E., Nielsen T., Qin J., Prifti E., Hildebrand F., Falony G., Almeida M., Arumugam M., Batto J.M., Kennedy S., et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500:541-546.
Not in our library10.1038/nature12506
- 98.
Fei N., Zhao L. An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME J. 2013;7:880-884.
Not in our library10.1038/ismej.2012.153
- 99.
Faith J.J., Ahern P.P., Ridaura V.K., Cheng J., Gordon J.I. Identifying gut microbe-host phenotype relationships using combinatorial communities in gnotobiotic mice. Sci. Transl. Med. 2014;6:220ra211.
Not in our library10.1126/scitranslmed.3008051
- 100.
Everard A., Belzer C., Geurts L., Ouwerkerk J.P., Druart C., Bindels L.B., Guiot Y., Derrien M., Muccioli G.G., Delzenne N.M., et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. USA. 2013;110:9066-9071.
Not in our library10.1073/pnas.1219451110
- 101.
Roopchand D.E., Carmody R.N., Kuhn P., Moskal K., Rojas-Silva P., Turnbaugh P.J., Raskin I. Dietary polyphenols promote growth of the gut bacterium Akkermansia muciniphila and attenuate high fat diet-induced metabolic syndrome. Diabetes. 2015;64:2847-2858.
Not in our library10.2337/db14-1916
- 102.
Dao M.C., Everard A., Aron-Wisnewsky J., Sokolovska N., Prifti E., Verger E.O., Kayser B.D., Levenez F., Chilloux J., Hoyles L., et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: Relationship with gut microbiome richness and ecology. Gut. 2016;65:426-436.
Not in our library10.1136/gutjnl-2014-308778
- 103.
Shin N.R., Lee J.C., Lee H.Y., Kim M.S., Whon T.W., Lee M.S., Bae J.W. An increase in the Akkermansia spp. Population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut. 2014;63:727-735.
Not in our library10.1136/gutjnl-2012-303839
- 104.
Behnsen J., Deriu E., Sassone-Corsi M., Raffatellu M. Probiotics: Properties, examples, and specific applications. Cold Spring Harb. Perspect. Med. 2013;3:a010074.
Not in our library10.1101/cshperspect.a010074
- 105.
Million M., Angelakis E., Paul M., Armougom F., Leibovici L., Raoult D. Comparative meta-analysis of the effect of lactobacillus species on weight gain in humans and animals. Microb. Pathog. 2012;53:100-108.
Not in our library10.1016/j.micpath.2012.05.007
- 106.
- 107.
Wu C.C., Weng W.L., Lai W.L., Tsai H.P., Liu W.H., Lee M.H., Tsai Y.C. Effect of Lactobacillus plantarum strain K21 on high-fat diet-fed obese mice. Evid. Based Complement. Altern. Med. 2015;2015:391767.
Not in our library10.1155/2015/391767
- 108.
Kadooka Y., Sato M., Ogawa A., Miyoshi M., Uenishi H., Ogawa H., Ikuyama K., Kagoshima M., Tsuchida T. Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial. Br. J. Nutr. 2013;110:1696-1703.
Not in our library10.1017/s0007114513001037
- 109.
Collado M.C., Isolauri E., Laitinen K., Salminen S. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am. J. Clin. Nutr. 2008;88:894-899.
Not in our library10.1093/ajcn/88.4.894
- 110.
Kalliomaki M., Collado M.C., Salminen S., Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am. J. Clin. Nutr. 2008;87:534-538.
Not in our library10.1093/ajcn/87.3.534
- 111.
Wu X., Ma C., Han L., Nawaz M., Gao F., Zhang X., Yu P., Zhao C., Li L., Zhou A., et al. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr. Microbiol. 2010;61:69-78.
Not in our library10.1007/s00284-010-9582-9
- 112.
Cani P.D., Neyrinck A.M., Fava F., Knauf C., Burcelin R.G., Tuohy K.M., Gibson G.R., Delzenne N.M. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 2007;50:2374-2383.
Not in our library10.1007/s00125-007-0791-0
- 113.
Cani P.D., Knauf C., Iglesias M.A., Drucker D.J., Delzenne N.M., Burcelin R. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes. 2006;55:1484-1490.
Not in our library10.2337/db05-1360
- 114.
Woting A., Pfeiffer N., Hanske L., Loh G., Klaus S., Blaut M. Alleviation of high fat diet-induced obesity by oligofructose in gnotobiotic mice is independent of presence of bifidobacterium longum. Mol. Nutr. Food Res. 2015;59:2267-2278.
Not in our library10.1002/mnfr.201500249
- 115.
Kondo S., Xiao J.Z., Satoh T., Odamaki T., Takahashi S., Sugahara H., Yaeshima T., Iwatsuki K., Kamei A., Abe K. Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity. Biosci. Biotechnol. Biochem. 2010;74:1656-1661.
Not in our library10.1271/bbb.100267
- 116.
Stenman L.K., Waget A., Garret C., Klopp P., Burcelin R., Lahtinen S. Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice. Benef. Microbes. 2014;5:437-445.
Not in our library10.3920/bm2014.0014
- 117.
Minami J., Kondo S., Yanagisawa N., Odamaki T., Xiao J.Z., Abe F., Nakajima S., Hamamoto Y., Saitoh S., Shimoda T. Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial. J. Nutr. Sci. 2015;4:e17.
Not in our library10.1017/jns.2015.5
Cited by papers we hold 13
- The critical role of gut microbiota in obesity · 2022No notice
- The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health · 2021No notice
- Gallstone Disease, Obesity and the Firmicutes/Bacteroidetes Ratio as a Possible Biomarker of Gut Dysbiosis · 2020No notice
- Differences in the gut Firmicutes to Bacteroidetes ratio across age groups in healthy Ukrainian population · 2020No notice
- Ketogenic diet enhances neurovascular function with altered gut microbiome in young healthy mice · 2018No notice
- Gastrointestinal Transit Time, Glucose Homeostasis and Metabolic Health: Modulation by Dietary Fibers · 2018No notice
- Gut microbiome diversity and high-fibre intake are related to lower long-term weight gain · 2017No notice
- Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial · 2017No notice
- Balancing Herbal Medicine and Functional Food for Prevention and Treatment of Cardiometabolic Diseases through Modulating Gut Microbiota · 2017No notice
- Human Gut Microbiota Associated with Obesity in Chinese Children and Adolescents · 2017No notice
- Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice · 2017No notice
- Microbiota, Inflammation and Colorectal Cancer · 2017No notice
- Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease · 2017No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.